A Metabolic Approach to Nash Management

This program will provide the latest information on the pathophysiology of NASH, the interplay between NASH and other components of metabolic syndrome, the importance of early intervention in NASH, emerging metabolic therapies for NASH treatment, and how to develop patient-personalized multidisciplinary treatment plans.

Faculty: 

Brent A. Tetri, MD

Stephen Harrison, MD, FACP, FAASLD, COL (ret.) USA, MC

Agenda

- Welcome and Introduction
- The Metabolic Nature of Nash
      -NASH pathophysiology
          -Role of genetics, diet, and hormones
          -Insulin resistance and hyperinsulinemia
   -Metabolic syndrome and NASH
         -Obesity as a risk factor for NASH
         -The pathogenic relationship between diabetes and NASH
         -Role of GLP-1 in NASH pathogenesis
- New Approaches to NASH Treatment
   -Importance of early intervention
   -Current treatment guidelines and pathways
   -Addressing the metabolic complications associated with NASH
   -Mechanism of action and early data with metabolic NASH therapies–
   -GLP-1 receptor agonists
         -PPAR agonists
         -SGLT2 inhibitors
         -Combination regimens
- Developing patient-personalized treatment plans
- Q&A and Discussion